πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 912 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9243051

Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T-cells

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Jan 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9238069

Method of sensitizing cancer cells to the cytotoxic effects of death receptor ligands in c

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jan 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9234179

Materials and methods for generating pluripotent stem cells

SHANGHAI UNITED STEM CELL BIOTECHNOLOGY CO., LTD. Β· Granted Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9228007

Recombinant human progenitor cells, engineered human thymocytes, and engineered human T ce

The Regents of the University of California Β· Granted Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9228171

Regulatory B cells (tBREGS) and their use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9220706

Inhibition of leukemic stem cells by PP2A activating agents

THE UNITED STATES OF AMERICA NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR) Β· Granted Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9217024

ADDL receptor polypeptides, polynucleotides and host cells for recombinant production

Acumen Pharmaceuticals, Inc. Β· Granted Tue Dec 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9210925

Multipotent postnatal stem cells from human periodontal ligament and uses thereof

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9205276

Light as a replacement for mitogenic factors on progenitor cells

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND SERVICES Β· Granted Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9192630

Transplantation of neural cells

The Regents of the University of California Β· Granted Tue Nov 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9192629

Isolated renal cells and uses thereof

REGENMEDTX, LLC Β· Granted Tue Nov 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9181231

Pyruvate kinase activators for use for increasing lifetime of the red blood cells and trea

Agios Pharmaceuticals, Inc. Β· Granted Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9175264

Postnatal stem cells and uses thereof

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9169495

Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact mi

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Oct 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9163215

Generation of lineage-restricted progenitor cells from differentiated cells

The Regents of the University of California Β· Granted Tue Oct 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9157069

Method of producing pancreatic hormone-producing cells

Takeda Pharmaceutical Company Limited Β· Granted Tue Oct 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9150831

Conditionally immortalized long-term stem cells and methods of making and using such cells

The Regents of the University of Colorado Β· Granted Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9132152

Compositions and methods for generating induced pluripotent stem cells

The Regents of the University of California Β· Granted Tue Sep 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9115371

Reduction of TGF beta signaling in myeloid cells in the treatment of cancer

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 25 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9114116

Neuroprotection by hepatic cells and hepatocyte secretory factors

Northwestern University Β· Granted Tue Aug 25 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9107897

Methods for isolating mammalian retinal progenitor cells

The Regents of the University of California Β· Granted Tue Aug 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9095562

Methods and compositions for optimized expansion and implantation of mesenchymal stem cell

REGENERATIVE SCIENCES, LLC Β· Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9085757

Production of insulin producing cells

Regents of the University of Minnesota Β· Granted Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9080148

Neuronal cells cultured on microparticles and methods of using the neuronal cells

The Regents of the University of California Β· Granted Tue Jul 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted